HHS: FDA COVID-19 emergency use authorizations remain in effect
Health and Human Services Secretary Xavier Becerra this week the February 2020 COVID-19 emergency use authorization declaration so that the Food and Drug Administration鈥檚 emergency use authorizations for COVID-19 diagnostics, personal protective equipment, other medical devices, and drug and biological products will remain in effect until there is no longer a 鈥渟ignificant potential鈥� for a COVID-19 public health emergency or the authorized devices or products have been approved. For more information, see the FDA鈥檚 .
Related News Articles
Headline
The Food and Drug Administration Nov. 9 cleared for marketing the Flowflex COVID-19 Antigen Home Test, the first COVID-19 antigen test and second COVID-19 at-鈥�
Headline
The Department of Health and Human Services鈥� Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19鈥�
Headline
The National Institute for Occupational Safety and Health this week revoked eight N95 filtering facepiece respirator approvals and four powered air-鈥�
Headline
In response to questions from AHA and others and informed by testing results, the Food and Drug Administration April 21 announced that health care鈥�
Headline
Health care providers and consumers should not use certain N95 respirators made by O&M Halyard because they do not meet quality and performance鈥�
Headline
The National Institute for Occupational Safety and Health recently rescinded all respirator approvals issued to Pacific PPE Corp. at the company鈥檚 request,鈥�